Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.42
-0.53 (-2.21%)
Sep 16, 2026, 4:00 PM EDT - Market closed
Immunome Market Cap
Immunome has a market cap or net worth of $2.66 billion as of September 16, 2026. Its market cap has increased by 222.76% in one year.
Market Cap
2.66B
Enterprise Value
2.15B
1-Year Change
222.76%
Ranking
Category
Stock Price
$23.42
ChartMarket Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.66B, an increase of 2,291.03%. That is a compound annual growth rate of 70.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 2.66B | 12.38% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 3.08B |
| Arcus Biosciences | 3.06B |
| Arcutis Biotherapeutics | 3.05B |
| MBX Biosciences | 2.87B |
| Zai Lab | 2.76B |
| Structure Therapeutics | 2.74B |
| Pharvaris | 2.73B |
| NewAmsterdam Pharma Company | 2.67B |